SCHEMBL7141097

SCHEMBL7141097

COc1cc(NC(=O)OC(C)(C)C)c([N+](=O)[O-])cc1-c1ccccc1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
GAA P10253 1/20 0.42
ABCB1 P08183 8/20 0.42
ABCC1 P33527 6/20 0.42
ALDH1A1 P00352 3/20 0.41
MAPT P10636 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CYP3A4 P08684 1/20 0.41
TSHR P16473 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
NPC1 O15118 1/20 0.41
MAPK1 P28482 1/20 0.41
USP2 O75604 1/20 0.41
MMP1 P03956 1/20 0.40
MMP2 P08253 1/20 0.40
MMP9 P14780 1/20 0.40
MMP8 P22894 1/20 0.40
MMP13 P45452 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7138538 0.92 RAB9A (0.41) RAB9AMEN1KMT2AGAAALDH1A1
SCHEMBL7141631 0.89 ABCC1 (0.42) RAB9AMEN1KMT2AABCB1ABCC1
SCHEMBL7146705 0.88 KDM4E (0.41) RAB9AMEN1KMT2AGAAALDH1A1
SCHEMBL6165508 0.87 MEN1 (0.38) RAB9AMEN1KMT2AGAAALDH1A1
SCHEMBL7143635 0.86 MEN1 (0.45) RAB9AMEN1KMT2AALDH1A1MAPT
SCHEMBL5557485 0.86 RAB9A (0.42) RAB9AMEN1KMT2AALDH1A1MAPT
SCHEMBL5562862 0.84 RAB9A (0.41) RAB9AMEN1KMT2AALDH1A1MAPT
SCHEMBL25381719 0.84 PKM (0.43) RAB9AMEN1KMT2AGAAABCB1
SCHEMBL7138373 0.84 ABCB1 (0.47) ABCB1ABCC1ALDH1A1MAPTMMP1
SCHEMBL7138568 0.84 ABCB1 (0.41) MEN1KMT2AGAAABCB1ABCC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed